Currently holds a position at Intra-Cellular Therapies Inc
Position | Company | Period |
---|---|---|
Senior Vice President, Late Stage Clinical Development and Medical Affairs | Intra-Cellular Therapies Inc | Aug. 20, 2018 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-11 | 2024-03-11 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
661
-3.2%
66.9644,261 USD |
661 -3.2% | 66.96 | 44,261 USD | |
2024-03-11 | 2024-03-11 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
872
-4.1%
65.8957,456 USD |
872 -4.1% | 65.89 | 57,456 USD | |
2024-03-11 | 2024-03-11 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
2,179
-9.3%
65.06141,766 USD |
2,179 -9.3% | 65.06 | 141,766 USD | |
2024-03-11 | 2024-03-07 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
2,722
-14.4%
66.86181,993 USD |
2,722 -14.4% | 66.86 | 181,993 USD | |
2024-03-11 | 2024-03-07 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
3,728
-16.5%
66.34247,316 USD |
3,728 -16.5% | 66.34 | 247,316 USD | |
2024-02-27 | 2024-02-26 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,312
-12.1%
71.0293,178 USD |
1,312 -12.1% | 71.02 | 93,178 USD | |
2024-02-27 | 2024-02-26 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,400
-11.5%
70.1698,224 USD |
1,400 -11.5% | 70.16 | 98,224 USD | |
2024-02-27 | 2024-02-26 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,400
-10.3%
69.3897,132 USD |
1,400 -10.3% | 69.38 | 97,132 USD | |
2024-02-05 | 2024-02-02 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
3,847
-40.3%
67.49259,634 USD |
3,847 -40.3% | 67.49 | 259,634 USD | |
2024-02-05 | 2024-02-02 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
2,320
-19.6%
66.69154,721 USD |
2,320 -19.6% | 66.69 | 154,721 USD | |
2024-01-04 | 2024-01-02 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
2,210
-100.0%
71.77158,612 USD |
2,210 -100.0% | 71.77 | 158,612 USD | |
2024-01-04 | 2024-01-02 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
22,645
-91.1%
70.801,603,266 USD |
22,645 -91.1% | 70.80 | 1,603,266 USD | |
2024-01-04 | 2024-01-02 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
37,427
-60.1%
70.412,635,235 USD |
37,427 -60.1% | 70.41 | 2,635,235 USD | |
2023-12-15 | 2023-12-13 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
21,262
-100.0%
65.001,382,030 USD |
21,262 -100.0% | 65.00 | 1,382,030 USD | |
2023-07-20 | 2023-07-17 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,842
-8.0%
65.00119,730 USD |
1,842 -8.0% | 65.00 | 119,730 USD | |
2023-03-13 | 2023-03-13 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
346
-1.5%
44.2915,324 USD |
346 -1.5% | 44.29 | 15,324 USD | |
2023-03-13 | 2023-03-13 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
6,998
-23.0%
45.08315,470 USD |
6,998 -23.0% | 45.08 | 315,470 USD | |
2023-02-22 | 2023-02-21 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
75
-0.3%
49.603,720 USD |
75 -0.3% | 49.60 | 3,720 USD | |
2023-02-22 | 2023-02-21 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
806
-3.4%
48.6339,196 USD |
806 -3.4% | 48.63 | 39,196 USD | |
2023-02-22 | 2023-02-21 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
800
-3.2%
47.2037,760 USD |
800 -3.2% | 47.20 | 37,760 USD | |
2023-02-22 | 2023-02-21 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
6,673
-21.2%
46.55310,628 USD |
6,673 -21.2% | 46.55 | 310,628 USD | |
2022-02-25 | 2022-02-24 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
681
-2.1%
51.3334,956 USD |
681 -2.1% | 51.33 | 34,956 USD | |
2022-02-25 | 2022-02-24 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
2,162
-6.4%
52.13112,705 USD |
2,162 -6.4% | 52.13 | 112,705 USD | |
2022-02-25 | 2022-02-24 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,203
-3.4%
53.0463,807 USD |
1,203 -3.4% | 53.04 | 63,807 USD | |
2022-02-23 | 2022-02-22 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,357
-4.7%
54.8074,364 USD |
1,357 -4.7% | 54.80 | 74,364 USD | |
2022-02-23 | 2022-02-22 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
2,820
-9.0%
55.53156,595 USD |
2,820 -9.0% | 55.53 | 156,595 USD | |
2022-01-20 | 2022-01-18 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
6,223
-21.2%
42.03261,553 USD |
6,223 -21.2% | 42.03 | 261,553 USD | |
2022-01-11 | 2022-01-10 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
500
-1.7%
39.8319,915 USD |
500 -1.7% | 39.83 | 19,915 USD | |
2022-01-11 | 2022-01-10 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
4,850
-14.0%
40.63197,056 USD |
4,850 -14.0% | 40.63 | 197,056 USD | |
2022-01-11 | 2022-01-10 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
1,520
-4.2%
41.4863,050 USD |
1,520 -4.2% | 41.48 | 63,050 USD | |
2021-02-22 | 2021-02-19 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
200
-0.9%
38.877,774 USD |
200 -0.9% | 38.87 | 7,774 USD | |
2021-02-22 | 2021-02-19 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
2,534
-9.8%
39.2899,536 USD |
2,534 -9.8% | 39.28 | 99,536 USD | |
2021-01-12 | 2021-01-11 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
100
-0.6%
31.603,160 USD |
100 -0.6% | 31.60 | 3,160 USD | |
2021-01-12 | 2021-01-11 |
Intra-Cellular Therapies Inc
(ITCI)
|
PS Planned sale |
4,267
-19.5%
32.13137,099 USD |
4,267 -19.5% | 32.13 | 137,099 USD |